Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease - ScienceDirect

Parkinson’s disease (PD) is a neurological disorder characterized by motor dysfunction, dopaminergic neuron loss, and alpha-synuclein (αSyn) inclusion…

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease, Microbiome

Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance - ScienceDirect

Frontiers Gut Bacteria Regulate the Pathogenesis of Huntington's Disease in Drosophila Model

Frontiers Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease

Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine

Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine

Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1 - Fang - 2019 - Journal of Neurochemistry - Wiley Online Library

Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis, Microbiome

The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer's disease - ScienceDirect

PDF) Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease - ScienceDirect

Frontiers Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model

Cell Reports, Vol 42, Issue 9, 26 September 2023